Prosidyan™ Announces FDA 510(k) Clearance of FIBERGRAFT™BG Putty – Bone Graft Substitute

Warren, NJ, March 26, 2015 –(PR.com)– NJ-based Prosidyan™ (www.prosidyan.com), developer of proprietary fiber-based bioactive glass products, announced today that it has received FDA 510(k) clearance of FIBERGRAFT™ BG Putty – Bone Graft Substitute. This is the second generation product in

Orthofix secures option to acquire eNeura for $65 million

By Jessica Achtsam On March 31, 2015, Orthofix International N.V. announced it entered into an 18-month option agreement to acquire eNeura, Inc. Orthofix’s website states that the focus of the company is on “improving patients’ lives by providing superior reconstructive and regenerative orthopedic

Hip resurfacing preserves bone mineral density, bone stock, but disadvantages must be considered

Although there is a high level of evidence that hip resurfacing arthroplasty preserves bone mineral density and bone stock in the proximal femur, the clinical relevance should be weighed against potential disadvantages, such as a higher revision rate f…

Stryker Spine Receives FDA Clearance for New Lumbar Plating System

ALLENDALE, N.J., March 25, 2015 /PRNewswire/ — Stryker Corporation’s Spine Division announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the LITe® Plate System, an Anterior and Lateral Lumbar Plate System.  The LITe Plate

Integra LifeSciences Announces the Filing of the Form 10 Registration Statement for the Planned Spin-off of the Orthobiologics and Spinal Fusion Hardware Business, SeaSpine

PLAINSBORO, N.J., April 1, 2015 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the filing of an initial Form 10 Registration Statement with the Securities and Exchange Commission (“SEC”) in connection with its previously announced plan to spin off SeaSpine

© 2025 MedDeviceJobs.com Powered by Careerleaf
v.4.6.1